Latest developments in MUC1 immunotherapyBiochemical Society Transactions - Tập 46 Số 3 - Trang 659-668 - 2018
Joyce Taylor‐Papadimitriou, Joy Burchell, Rosalind Graham, Richard Beatson
Currently, there is renewed interest in attempting to recruit the host immune
system to eliminate cancers, and within this renewed activity, MUC1 continues to
arouse interest. MUC1 has been considered a possible therapeutic target for the
past 30 years as it is up-regulated, aberrantly glycosylated and its
polarization is lost in many adenocarcinomas. Moreover, MUC1 is expressed by
some haematopoi... hiện toàn bộ
Glyoxalase I inhibitors in cancer chemotherapyBiochemical Society Transactions - Tập 31 Số 6 - Trang 1378-1382 - 2003
Donald J. Creighton, Zhe-Bin Zheng, Ronald J. Holewinski, Diana S. Hamilton, Julie L. Eiseman
Several recent developments suggest that the GSH-dependent glyoxalase enzyme
system deserves renewed interest as a potential target for antitumour drug
development. This summary focuses on the design and development of new classes
of tumoricidal agents that specifically target this elementary detoxification
pathway in order to induce elevated concentrations of cytotoxic methylglyoxal in
tumour cel... hiện toàn bộ
Systems biology markup language: Level 2 and beyondBiochemical Society Transactions - Tập 31 Số 6 - Trang 1472-1473 - 2003
Andrew Finney, Michael Hucka
The SBML (systems biology markup language) is a standard exchange format for
computational models of biochemical networks. We continue developing SBML
collaboratively with the modelling community to meet their evolving needs. The
recently introduced SBML Level 2 includes several enhancements to the original
Level 1, and features under development for SBML Level 3 include model
composition, multist... hiện toàn bộ
Tau protein in Alzheimer's diseaseBiochemical Society Transactions - Tập 23 Số 1 - Trang 80-86 - 1995
Michel Goedert, Ross Jakes, Maria Grazia Spillantini, R. Anthony Crowther, Phillip Cohen, Eugeen Vanmechelen, A. Probst, Jürgen Götz, Kurt Bürki